Mark Rogge

Mark Rogge

Takeda Pharmaceutical Company Limited - Osaka / Japan
Others
AD Scientific Index ID: 4406034
武田薬品工業株式会社
person_outline Mark Rogge's MOST POPULAR ARTICLES
1-) Self-emulsifying drug delivery systems: formulation and biopharmaceutic evaluation of an investigational lipophilic compoundSA Charman, WN Charman, MC Rogge, TD Wilson, FJ Dutko, CW PoutonPharmaceutical research 9 (1), 87-93, 19926051992
2-) Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous dosesSC Chien, MC Rogge, LG Gisclon, C Curtin, F Wong, J Natarajan, ...Antimicrobial agents and chemotherapy 41 (10), 2256-2260, 19972951997
3-) Effect of food and a monoglyceride emulsion formulation on danazol bioavailabilityWN Charman, MC Rogge, AW Boddy, BM BergerThe Journal of Clinical Pharmacology 33 (4), 381-386, 19931731993
4-) Pharmacokinetic profiles of ciprofloxacin after single intravenous and oral dosesJT Lettieri, MC Rogge, L Kaiser, RM Echols, AH HellerAntimicrobial agents and chemotherapy 36 (5), 993-996, 19921661992
5-) Population pharmacokinetic and pharmacodynamic modeling of etanercept using logistic regression analysisH Lee, HC Kimko, M Rogge, D Wang, I Nestorov, CC PeckClinical Pharmacology & Therapeutics 73 (4), 348-365, 20031422003